0000899243-21-033275.txt : 20210817 0000899243-21-033275.hdr.sgml : 20210817 20210817172225 ACCESSION NUMBER: 0000899243-21-033275 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210816 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wyzga Michael D CENTRAL INDEX KEY: 0001877600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 211184038 MAIL ADDRESS: STREET 1: C/O YUMANITY, INC. STREET 2: 40 GUEST STREET, SUITE 4410 CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: YUMANITY THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET STREET 2: SUITE 4410 CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-409-5300 MAIL ADDRESS: STREET 1: 40 GUEST STREET STREET 2: SUITE 4410 CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-16 0 0001445283 YUMANITY THERAPEUTICS, INC. YMTX 0001877600 Wyzga Michael D C/O YUMANITY THERAPEUTICS, INC. 40 GUEST STREET, SUITE 4410 BOSTON MA 02135 0 1 0 0 See Remarks Stock Option (Right to Buy) 9.17 2021-08-16 4 A 0 65000 0.00 A 2031-08-15 Common Stock 65000 65000 D 25% of the shares subject to the option shall vest on August 16, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years. Sr. VP & Chief Financial Officer /s/ Marie Epstein, Attorney-in-Fact 2021-08-17